Mh. Zou et al., Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries, AM J PATH, 154(5), 1999, pp. 1359-1365
Citations number
20
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Prostacyclin synthase (PCS) is an enzyme with antithrombotic, antiprolifera
tive, and dilatory functions in the normal vasculature, and inactivation of
PCS by tyrosine nitration may favor atherosclerotic processes. Here, we sh
ow that PCS is nitrated and inactivated in early stage atherosclerotic lesi
ons (focal intimal thickenings). Immunoprecipitation with antibodies raised
against nitrotyrosine yielded PCS as the main nitrated protein in blood ve
ssels. Moreover, we identified two nitrated degradation products of PCS wit
h molecular mass of 30 and 46 kd, which were selective for atherosclerotic
tissue. Agonist (acetylcholine, angiotensin II)-induced prostacyclin format
ion was decreased in atherosclerotic vessels compared with normal tissue, w
hereas PGE(2) formation was increased and cyclooxygenase activity remained
unchanged. A selective loss of PCS activity was confirmed by direct measure
ment of enzymatic activity. In line with this, we observed defective relaxa
tion of early atherosclerotic vessels following vasoconstrictive stimulatio
n, This functional impairment was completely reversed by coincubation with
an antagonist of the thromboxane/PGH(2) receptor but not by a thromboxane s
ynthase inhibitor. These data suggest that reduced PCS activity in atherosc
lerotic arteries prevents the rapid use of PGH(2), which accumulates and ac
ts as an agonist on the vasoconstrictive thromboxane receptor.